BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34886876)

  • 1. Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol.
    Gonçalves G; Campos MP; Gonçalves AS; Medeiros LCS; Figueiredo FB
    Parasit Vectors; 2021 Dec; 14(1):599. PubMed ID: 34886876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
    Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
    Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miltefosine-resistant Leishmania infantum strains with an impaired MT/ROS3 transporter complex retain amphotericin B susceptibility.
    Mondelaers A; Hendrickx S; Van Bockstal L; Maes L; Caljon G
    J Antimicrob Chemother; 2018 Feb; 73(2):392-394. PubMed ID: 29165590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
    Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
    Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum.
    Farca AM; Miniscalco B; Badino P; Odore R; Monticelli P; Trisciuoglio A; Ferroglio E
    Parasitol Res; 2012 Jun; 110(6):2509-13. PubMed ID: 22218923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in Leishmania infantum.
    Hendrickx S; Beyers J; Mondelaers A; Eberhardt E; Lachaud L; Delputte P; Cos P; Maes L
    J Antimicrob Chemother; 2016 Jul; 71(7):1914-21. PubMed ID: 27084919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.
    Gómez Pérez V; García-Hernandez R; Corpas-López V; Tomás AM; Martín-Sanchez J; Castanys S; Gamarro F
    Int J Parasitol Drugs Drug Resist; 2016 Aug; 6(2):133-9. PubMed ID: 27317865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasis.
    Dias ÁFLR; Ayres EDCBS; de Oliveira Martins DT; Maruyama FH; de Oliveira RG; de Carvalho MR; Almeida ADBPF; Teixeira ALS; Mendonça AJ; Sousa VRF
    Exp Parasitol; 2020 Oct; 217():107947. PubMed ID: 32628971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
    Medkour H; Bitam I; Laidoudi Y; Lafri I; Lounas A; Hamidat HK; Mekroud A; Varloud M; Davoust B; Mediannikov O
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008947. PubMed ID: 33338041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil.
    Dos Santos Nogueira F; Avino VC; Galvis-Ovallos F; Pereira-Chioccola VL; Moreira MAB; Romariz APPL; Molla LM; Menz I
    Parasit Vectors; 2019 Feb; 12(1):79. PubMed ID: 30736866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
    Oliva G; Foglia Manzillo V; Pagano A
    Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility to antimonials and amphotericin B of Leishmania infantum strains isolated from dogs in a region lacking drug selection pressure.
    Aït-Oudhia K; Gazanion E; Sereno D; Oury B; Dedet JP; Pratlong F; Lachaud L
    Vet Parasitol; 2012 Jul; 187(3-4):386-93. PubMed ID: 22349936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and parasitological impact of short-term treatment using miltefosine and allopurinol monotherapy or combination therapy in canine visceral leishmaniasis.
    Ayres EDCBS; Dias ÁFLR; Monteiro BRG; Pazzini SS; Barbosa MEC; Silva EBD; Macedo LFDC; Sousa VRF; Dutra V; Nakazato L; Almeida ADBPF
    Rev Bras Parasitol Vet; 2022; 31(3):e007222. PubMed ID: 35920471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of
    Özbilgin A; Çavuş İ; Kaya T; Yıldırım A; Harman M
    Turkiye Parazitol Derg; 2020 Mar; 44(1):12-16. PubMed ID: 32212583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights with miltefosine unresponsiveness in Brazilian Leishmania infantum isolates.
    Bhattacharya A; Ouellette M
    EBioMedicine; 2018 Nov; 37():13-14. PubMed ID: 30314891
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum.
    Dos Santos CCP; Ramos GS; De Paula RC; Faria KF; Moreira POL; Pereira RA; Melo MN; Tafuri WL; Demicheli C; Ribeiro RR; Azevedo EG; Do Monte-Neto R; Da Silva SM; Frézard F
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32284386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, blinded, controlled clinical trial comparing the efficacy of aminosidine (paromomycin)-allopurinol combination with the efficacy of meglumine antimoniate-allopurinol combination for the treatment of canine leishmaniosis due to Leishmania infantum.
    Kasabalis D; Chatzis MK; Apostolidis K; Petanides T; Athanasiou LV; Xenoulis PG; Mataragka A; Ikonomopoulos J; Leontides LS; Saridomichelakis MN
    Exp Parasitol; 2020 Jul; 214():107903. PubMed ID: 32360142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
    Reimão JQ; Oliveira JC; Trinconi CT; Cotrim PC; Coelho AC; Uliana SR
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003556. PubMed ID: 25679212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientometric analysis of chemotherapy of canine leishmaniasis (2000-2020).
    Olías-Molero AI; Fontán-Matilla E; Cuquerella M; Alunda JM
    Parasit Vectors; 2021 Jan; 14(1):36. PubMed ID: 33422141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
    Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
    Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.